Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells
NCT00562666
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
OTHER:
T gamma delta lymphocytes
Sponsor
Rennes University Hospital
Collaborators
[object Object]